| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/08/1992 | EP0479627A1 Vaccinal association against infections pathogens |
| 04/08/1992 | EP0479600A2 Delivery of agents |
| 04/08/1992 | EP0479597A2 Process for producing secretory immunoglobulin-A preparations |
| 04/08/1992 | EP0479454A1 HIV-neutralizing rat monoclonal antibodies against PB-1 |
| 04/08/1992 | EP0479376A1 Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
| 04/08/1992 | EP0479280A1 T cell vaccination for prevention and treatment of allergy or graft rejection |
| 04/08/1992 | EP0478689A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1 MN? gp 120 |
| 04/08/1992 | EP0478665A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
| 04/08/1992 | EP0478664A1 Vector-mediated genomic insertion and expression of dna in bcg |
| 04/08/1992 | CN1060110A Cultivation method for preparing oral live typhoid vaccine |
| 04/08/1992 | CN1060027A Improved adjuvants and vaccines |
| 04/07/1992 | US5102990 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 04/07/1992 | US5102872 Protein conjugated to polyoxyethylene mixed with time-releasing human serum albumin, encapsulated in poly(lactide-co-glycolide) microcapsules; treating shipping fever and other stress related diseases in cattle |
| 04/07/1992 | US5102807 Inhibin isolated from ovarian follicular fluid |
| 04/07/1992 | US5102663 Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3 |
| 04/07/1992 | CA1298555C Anticoccidial method |
| 04/07/1992 | CA1298554C 2-component immunoadjuvant |
| 04/07/1992 | CA1298553C Reduction of reproductive losses |
| 04/06/1992 | WO1992005698A1 Regulation of immunoglobulin production by interleukin-9 |
| 04/06/1992 | CA2052809A1 Process for producing secretory immunoglobulin a preparations |
| 04/06/1992 | CA2052702A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 04/04/1992 | WO1992006119A1 Method for treating inflammation using anti-idiotypic antibodies |
| 04/04/1992 | CA2092801A1 Method for treating inflammation using anti-idiotypic antibodies |
| 04/02/1992 | WO1992006218A1 A novel onco-fetal gene, gene product and uses therefor |
| 04/02/1992 | WO1992005274A1 Framework mutated antibodies and their preparation |
| 04/02/1992 | WO1992005263A1 Viral defective vaccine produced by transcomplementing cell line |
| 04/02/1992 | WO1992005262A1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/02/1992 | WO1992005256A1 Natural killer stimulatory factor |
| 04/02/1992 | WO1992005254A1 Novel neurothrophic factor |
| 04/02/1992 | WO1992005248A1 Human papilloma viral protein expression for use in vaccine compositions |
| 04/02/1992 | WO1992005197A1 Purification of cytokeratin fragments |
| 04/02/1992 | WO1992005196A1 Aids therapy and vaccine |
| 04/02/1992 | WO1992005193A1 Plasmodium liver stage antigens |
| 04/02/1992 | WO1992005192A1 T-cell epitopes |
| 04/02/1992 | WO1992005184A1 A non-mitogenic competitive hgf antagonist |
| 04/02/1992 | WO1992004914A1 Design of bioactive peptides based on immunoglobulin structure |
| 04/02/1992 | WO1992004887A1 Induction of cytotoxic t cell |
| 04/02/1992 | WO1991009872A3 Hiv-1 env fragment fusion protein |
| 04/02/1992 | CA2092916A1 Onco-fetal gene, gene product and uses therefor |
| 04/02/1992 | CA2091258A1 Design of bioactive peptides based on immunoglobulin structure |
| 04/02/1992 | CA2069507A1 Aids therapy and vaccine |
| 04/02/1992 | CA2052459A1 Vaccinal association against infective pathogenic agents |
| 04/01/1992 | EP0478366A2 Recombinant hybrid immunoglobulin molecules and method of use |
| 04/01/1992 | EP0478017A1 Monoclonal antibody with specificity for human myosin light chains |
| 04/01/1992 | EP0477968A1 Extract from Ginkgo biloba leaves, in particular for intravenous injection or infusion, a method of preparation of the extract and ampoule preparations containing the extract |
| 04/01/1992 | EP0477508A1 Improved oligosaccharide conjugate vaccines |
| 04/01/1992 | EP0477301A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection |
| 04/01/1992 | EP0477226A1 Contraceptive vaccine based on cloned zona pellucida gene |
| 04/01/1992 | EP0477201A1 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic application thereof |
| 04/01/1992 | EP0324811B1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 03/31/1992 | US5101019 Method for removing pertussis endotoxin, a pertussis toxoid and its production |
| 03/31/1992 | US5101015 Nitrogen-functional-group-containing immunogen |
| 03/31/1992 | US5101014 Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis |
| 03/31/1992 | US5100664 Human IL-2 as a vaccine adjuvant |
| 03/31/1992 | US5100663 Tyr-Gly compositions useful in increasing immune response |
| 03/31/1992 | US5100662 Steroidal liposomes exhibiting enhanced stability |
| 03/29/1992 | WO1992006113A2 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT |
| 03/29/1992 | CA2092827A1 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 03/29/1992 | CA2052324A1 Insertion of dna by modified transposons |
| 03/28/1992 | WO1992006115A1 Antagonists of human gamma interferon |
| 03/28/1992 | CA2092541A1 Antagonists of human gamma interferon |
| 03/28/1992 | CA2052283A1 Recombinant hybrid immunoglobulin molecules and method of use |
| 03/26/1992 | WO1992005194A1 Vaccine suitable for combatting bordetella pertussis |
| 03/25/1992 | EP0477056A1 Recombinant herpes viruses, vaccines comprising them, process for preparation and US 3 genes |
| 03/25/1992 | EP0476953A2 Viral targeted destruction of neoplastic cells |
| 03/25/1992 | EP0476408A1 Chemical conjugation of morpholino anthracyclines to antibodies |
| 03/25/1992 | EP0476287A2 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis |
| 03/25/1992 | EP0476130A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 03/25/1992 | EP0475987A1 Vaccine against hiv |
| 03/25/1992 | CN1059758A Non-a, non-b hepatitis virus particles |
| 03/25/1992 | CA2050817A1 Hiv-neutralizing rat monoclonal antibodies against pb-1 |
| 03/24/1992 | US5099004 Antibodies such as monoclonal antibodies |
| 03/24/1992 | US5099002 Sequential improved method for treatment of human blood-clotting factor products |
| 03/24/1992 | US5098998 Protection against Vibrio |
| 03/24/1992 | US5098997 Vaccines for Haemophilus influenzae |
| 03/24/1992 | US5098827 Novel bacterial markers for pathogenic group B streptococci |
| 03/24/1992 | US5098704 Hepatitis surface antigen particle vaccine |
| 03/24/1992 | CA1297818C Anti-urokinase monoclonal antibody, matrix bearing it, test method and biochemical test kits which use it |
| 03/24/1992 | CA1297816C Platelet function inhibiting monoclonal antibody fragment |
| 03/24/1992 | CA1297815C Fibrinogen blocking monoclonal antibody |
| 03/22/1992 | CA2051829A1 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis |
| 03/19/1992 | WO1992004632A1 Methods for the diagnosis and treatment of diabetes |
| 03/19/1992 | WO1992004461A1 Genetically engineered coccidiosis vaccine |
| 03/19/1992 | WO1992004460A1 Genetically engineered coccidiosis vaccine |
| 03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
| 03/19/1992 | WO1992004445A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/19/1992 | WO1992004380A1 Specific binding agents |
| 03/19/1992 | WO1992004375A1 Hrsv vaccine |
| 03/19/1992 | WO1992004055A1 Immunosuppressant composition |
| 03/19/1992 | WO1992004052A1 Modified antibodies with controlled clearance time |
| 03/19/1992 | WO1992004051A1 Monoclonal antibody active against the interleukin-2 receptor |
| 03/19/1992 | WO1992004050A1 Recombinant herpes simplex viruses vaccines and methods |
| 03/19/1992 | WO1992004035A1 Anti-inflammatory factor, method of isolation, and use |
| 03/19/1992 | WO1992004033A1 Methods for inhibiting rejection of transplanted tissue |
| 03/19/1992 | WO1992004009A1 Liposomes |
| 03/19/1992 | WO1992003918A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 03/19/1992 | DE4029227A1 Arzneimittel enthaltend cd14 Medicines containing CD14 |
| 03/19/1992 | DE4028955A1 Monoklonale antikoerper gegen den interleukin 2-rezeptor Monoclonal antibodies against the interleukin 2 receptor |
| 03/18/1992 | WO1992005264A1 Multiple promoter baculovirus expression system and defective particle production |
| 03/18/1992 | WO1992004915A1 Improved vaccine compositions |